IMP dehydrogenase 2 is the rate-limiting enzyme in the de novo guanine nucleotide biosynthesis. It is thus involved in maintaining cellular guanine deoxy- and ribonucleotide pools needed for DNA and RNA synthesis. IMPDH2 catalyzes the NAD-dependent oxidation of inosine-5'-monophosphate into xanthine-5'-monophosphate, which is then converted into guanosine-5'-monophosphate.
IMPDH2 shares 84% amino acid identity with IMPDH1. They identified 4 Sp1-binding sites but did not identify a TATA box. The transcriptional start sites were determined by S1 nuclease mapping to be somewhat heterogeneous, but the predominant mRNA species showed a 5-prime end at 102 and 85 nucleotides from the translational initiation codon.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | RPF632Hu01 | Recombinant Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | MAF632Hu21 | Monoclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | WB; IHC; ICC; IP. |
PAF632Hu01 | Polyclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | WB; IHC; ICC; IP. | |
Assay Kits | SEF632Hu | ELISA Kit for Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Inosine 5'-Monophosphate Dehydrogenase 2 (IMPDH2) | ELISA Kit Customized Service Offer |
- "Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs."J. Biol. Chem. 263:15769-15772(1988) [PubMed] [Europe PMC] [Abstract]
- "Two distinct cDNAs for human IMP dehydrogenase."J. Biol. Chem. 265:5292-5295(1990) [PubMed] [Europe PMC] [Abstract]
- "Cloning and sequence of the human type II IMP dehydrogenase gene."Biochem. Biophys. Res. Commun. 205:537-544(1994) [PubMed] [Europe PMC] [Abstract]
- "Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene."J. Biol. Chem. 270:6808-6814(1995) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Chromosomal localization and structure of the human type II IMP dehydrogenase gene."Genomics 16:274-277(1993) [PubMed] [Europe PMC] [Abstract]
- "Characterization of human type I and type II IMP dehydrogenases."J. Biol. Chem. 268:27286-27290(1993) [PubMed] [Europe PMC] [Abstract]
- "Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding."Biochem. Pharmacol. 49:1323-1329(1995) [PubMed] [Europe PMC] [Abstract]
- "Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo."Biochem. J. 379:243-251(2004) [PubMed] [Europe PMC] [Abstract]
- "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract]
- "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
- "A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity."Pharmacogenet. Genomics 17:283-290(2007) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
- "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
- "Lysine acetylation targets protein complexes and co-regulates major cellular functions."Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
- "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
- "Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design."Proc. Natl. Acad. Sci. U.S.A. 96:3531-3536(1999) [PubMed] [Europe PMC] [Abstract]
- "Crystal structure of human inosine monophosphate dehydrogenase type II complexed with the MPA/NAD analog C2-MAD."Submitted (DEC-2002) to the PDB data bank
- "The conformation of NAD bound to human inosine monophosphate Dehydrogenase Type II."Submitted (DEC-2002) to the PDB data bank